RMG Wealth Management
WST icon

RMG Wealth Management’s West Pharmaceutical WST Stock Holding History

RMG Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.96K Hold
5
– – ﹤0.01% 424
2026
Q2 		$1.76K Hold
5
– – ﹤0.01% 454
2026
Q1 		$1.61K Hold
5
– – ﹤0.01% 521
2025
Q4 		$1.27K Buy
+5
New +$1.37K ﹤0.01% 377

Other funds holding WST

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

RMG Wealth Management's WST Position: Q3 2026 in Review

RMG Wealth Management held its West Pharmaceutical (WST) position steady in Q3 2026 at 5 shares worth $1.96K. The position accounts for ﹤0.01% of the portfolio, ranked #424.

RMG Wealth Management first reported a position in WST in Q4 2025 and has held it in 4 quarters since. 430 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • RMG Wealth Management held 5 shares of West Pharmaceutical worth $1.96K as of Q3 2026.
  • RMG Wealth Management left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of RMG Wealth Management's portfolio in Q3 2026, its #424 holding.
  • RMG Wealth Management first reported a position in West Pharmaceutical in Q4 2025 and has held it in 4 quarters since.
  • 430 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on RMG Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.